Second-Line Therapies After Treatment with Fludarabine, Cyclophosphamide, and Rituximab (FCR) or Fludarabine and Cyclophosphamid Alone (FC) for Chronic Lymphocytic Leukemia (CLL) within the CLL8-Protocol of the German CLL Study Group (GCLLSG)
暂无分享,去创建一个
H. Döhner | M. Hallek | C. Wendtner | M. Kneba | R. Busch | A. Fink | K. Fischer | M. Rieger | J. Mayer | P. Cramer | B. Eichhorst | N. Pflug | Friederike Schubert